| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Neurocrine Biosciences, Inc. (NBIX) has 17 insiders with recent SEC Form 4 filings, including 0 buys and 12 sells. NBIX is classified in the Pharmaceuticals industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 140.4K | $22.69M | - | |
| Other | 52.8K | $8.53M | - | |
| Other | 46.8K | $7.56M | - | |
| Other | 39.6K | $6.41M | -36,937 | |
| Other | 36.8K | $5.96M | -22,000 |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Feb 10, 2025 | Benevich Eric62 | Chief Commercial Officer | Sale+OE | 980 | $118.31 | $115,940.37 | -2.2% | +1.4% | +15.9% | |
| Feb 10, 2025 | Abernethy Matt57 | Chief Financial Officer | Sale+OE | 980 | $118.27 | $115,908.52 | -2.8% | +1.4% | +15.9% | |
| Feb 10, 2025 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 980 | $118.22 | $115,852.66 | -2.9% | +1.4% | +15.9% | |
| Feb 10, 2025 | Lippoldt Darin60 | Chief Legal Officer | Sale+OE | 911 | $118.25 | $107,727.03 | -2.1% | +1.4% | +15.9% | |
| Feb 10, 2025 | Gano Kyle54 | Chief Executive Officer | Sale+OE | 980 | $118.39 | $116,020.34 | -0.7% | +1.4% | +15.9% | |
| Feb 10, 2025 | Boyer David W.51 | Chief Corp. Affairs Officer | Sale+OE | 700 | $118.31 | $82,820.08 | -25.9% | +1.4% | +15.9% | |
| Feb 10, 2025 | Gorman Kevin Charles55 | Director | Sale+OE | 2,274 | $118.37 | $269,167.24 | -0.4% | +1.4% | +15.9% | |
| Feb 3, 2025 | Delaet Ingrid67 | Chief Regulatory Officer | Sale+OE | 1,045 | $150.81 | $157,594.39 | -14.2% | -26.9% | -7.4% | |
| Jan 31, 2025 | Cooke Julie59 | Chief Human Resources Officer | Sale+OE | 1,740 | $152.89 | $266,024.95 | -4.5% | -29.8% | -10.4% | |
| Jan 31, 2025 | Roberts Eiry49 | Chief Medical Officer | Sale+OE | 1,457 | $152.80 | $222,636.16 | -4.3% | -29.8% | -10.4% |